Erratum to: Cancer Cell Int (2016) 16:19 DOI 10.1186/s12935-016-0292-7
Upon publication of the original article [1], it was noted that the Core Facilities utilized by the authors for their research were not adequately acknowledged in the manuscript. In this case, the following was mistakenly omitted:
-
Progenitor cell analysis core
-
Molecular Phenotyping core
-
Stem Cell COBRE Grant P30GM106391
-
Vascular Biology COBRE Grant P30GM103392
This has since been acknowledged and corrected in this erratum.
Reference
Jing H, Liaw L, Friesel R, Vary C, Hua S, Yang X. Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells. Cancer Cell Int. 2016;16(1):19. doi:10.1186/s12935-016-0292-7.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/s12935-016-0292-7.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Jing, H., Liaw, L., Friesel, R. et al. Erratum to: Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells. Cancer Cell Int 17, 53 (2017). https://doi.org/10.1186/s12935-017-0423-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12935-017-0423-9